Characterization and Drug Resistance Patterns of Ewing's Sarcoma Family Tumor Cell LinesWilliam A. May(University of Southern California), C. Patrick Reynolds(St. Jude Children's Research Hospital)PLoS ONEDecember 2, 201310.1371/journal.pone.0080060Cited by 61SaveCiteExport RISWatch citationsRelated PapersActivity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo|Blood|2007|155FOXM1 Is an Oncogenic Mediator in Ewing Sarcoma|PLoS ONE|2013|40Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial|Pediatric Blood & Cancer|2018|39Supplementary Data from Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma|Unknown|2023|0